Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record review, staff interview, staff attestation statements and time clock record review, the facility failed to keep an accurate medical record for one resident. This affected one resident (Resident #5) and had the potential to affect 28 residents (Resident #37, #4, #65, #29, #66, #21, #45, #47, #171, #68, #39, #55, #54, #40, #59, #53, #26, #5, #69, #33, #22, #8, #64, #58, #38, #56, and Former Residents #200 and 201) that were residing on the first and second floors of the facility on 01/9/25.
Findings include:
Review of Resident #5's medical record revealed that she was admitted to the facility on [DATE] with diagnoses that included hypertension (HTN), gastroesophageal reflux disease (GERD), polyarthritis, major depressive disorder, primary osteoarthritis, chronic kidney disease (CKD), Vitamin B-12 deficiency, and Vitamin D deficiency.
Review of Resident #5's physician orders revealed that effective on 03/01/24, she was prescribed Amlodipine Besylate 5 milligrams (mg) one tablet once daily for hypertension, Aspirin 81 mg one tablet once daily for prevention, Diltiazem 24 hour extended release 240 mg one capsule once daily for hypertension, Fluoxetine HCl 40 mg one capsule once daily for major depressive disorder, Omeprazole Delayed Release 20 mg one capsule once daily for GERD, Vitamin B-12 1000 micrograms (mcg) one tablet once daily for Vitamin B-12 deficiency, Vitamin D3 50 mcg one tablet once daily for Vitamin D3 deficiency, Carvedilol 12.5 mg one tablet twice daily for hypertension, Clonidine HCl 100 mg one tablet twice daily for hypertension, Hydralazine 100 mg one tablet twice daily for hypertension, Oysco 500 mg one tablet twice daily, and Tylenol Arthritis Extended Release 650 mg 1 tablet twice daily; Effective 08/21/24, she was prescribed Torsemide, a diuretic, 10 mg one tablet once daily for CKD; Effective 04/19/24, she was prescribed Losartan Potassium 50 mg one tablet once daily for hypertension.
Review of Resident #5's Medication Administration Record (MAR) revealed that on 01/09/25, there was no evidence that the following medications had been administered in the morning: Amlodipine Besylate 5 mg one tablet, Aspirin 81 mg one tablet, Diltiazem 24 hour extended release 240 mg one capsule, Fluoxetine HCl 40 mg one capsule, Omeprazole Delayed Release 20 mg one capsule, Vitamin B-12 1000 mcg one tablet, Vitamin D3 50 mcg one tablet, Carvedilol 12.5 mg one tablet, Clonidine HCl 100 mg one tablet, Hydralazine 100 mg, Oysco 500 mg one tablet, and Tylenol Arthritis Extended Release 650 mg one tablet, Torsemide10 mg one tablet, and Losartan Potassium 50 mg one tablet.
Review of Resident #5's medical record revealed that she had not had any adverse reactions as a result of the medication administration not being administered.
Interview with Resident #5 on 04/03/25 at 9:45 A.M. revealed that she did not recall a time where she was not given her morning medications.
Interview with the Director of Nursing on 04/03/25 at 9:30 A.M. revealed there was no evidence in the medical chart that the medications had been administered to Resident #5 on the morning of 01/09/25.
Review of the time sheets for Licensed Practical Nurse (LPN) #170 for 01/09/25 revealed that she was on duty at the facility on 01/09/25 from 8:20 A.M. until 12:52 P.M.
Review of the attestation statements on 04/03/25 authored by Scheduler #175, Registered Nurse #155, and the Director of Nursing regarding the events of 01/09/25 revealed that on 01/09/25, LPN #170 was the nurse working on the first and second floors of the facility. She left the building on 01/09/25 at 12:52 P.M. after claiming she was too anxious to complete her shift. LPN #170 left the faciity on [DATE] without signing off the medication administration record in its entirety for Resident #5. RN #155, a member of the facility's nursing administration team, completed the duration of LPN #170's shift, and LPN #170 was reported to the nursing board for job abandonment.
Findings include:
Review of Resident #5's medical record revealed that she was admitted to the facility on [DATE] with diagnoses that included hypertension (HTN), gastroesophageal reflux disease (GERD), polyarthritis, major depressive disorder, primary osteoarthritis, chronic kidney disease (CKD), Vitamin B-12 deficiency, and Vitamin D deficiency.
Review of Resident #5's physician orders revealed that effective on 03/01/24, she was prescribed Amlodipine Besylate 5 milligrams (mg) one tablet once daily for hypertension, Aspirin 81 mg one tablet once daily for prevention, Diltiazem 24 hour extended release 240 mg one capsule once daily for hypertension, Fluoxetine HCl 40 mg one capsule once daily for major depressive disorder, Omeprazole Delayed Release 20 mg one capsule once daily for GERD, Vitamin B-12 1000 micrograms (mcg) one tablet once daily for Vitamin B-12 deficiency, Vitamin D3 50 mcg one tablet once daily for Vitamin D3 deficiency, Carvedilol 12.5 mg one tablet twice daily for hypertension, Clonidine HCl 100 mg one tablet twice daily for hypertension, Hydralazine 100 mg one tablet twice daily for hypertension, Oysco 500 mg one tablet twice daily, and Tylenol Arthritis Extended Release 650 mg 1 tablet twice daily; Effective 08/21/24, she was prescribed Torsemide, a diuretic, 10 mg one tablet once daily for CKD; Effective 04/19/24, she was prescribed Losartan Potassium 50 mg one tablet once daily for hypertension.
Review of Resident #5's Medication Administration Record (MAR) revealed that on 01/09/25, there was no evidence that the following medications had been administered in the morning: Amlodipine Besylate 5 mg one tablet, Aspirin 81 mg one tablet, Diltiazem 24 hour extended release 240 mg one capsule, Fluoxetine HCl 40 mg one capsule, Omeprazole Delayed Release 20 mg one capsule, Vitamin B-12 1000 mcg one tablet, Vitamin D3 50 mcg one tablet, Carvedilol 12.5 mg one tablet, Clonidine HCl 100 mg one tablet, Hydralazine 100 mg, Oysco 500 mg one tablet, and Tylenol Arthritis Extended Release 650 mg one tablet, Torsemide10 mg one tablet, and Losartan Potassium 50 mg one tablet.
Review of Resident #5's medical record revealed that she had not had any adverse reactions as a result of the medication administration not being administered.
Interview with Resident #5 on 04/03/25 at 9:45 A.M. revealed that she did not recall a time where she was not given her morning medications.
Interview with the Director of Nursing on 04/03/25 at 9:30 A.M. revealed there was no evidence in the medical chart that the medications had been administered to Resident #5 on the morning of 01/09/25.
Review of the time sheets for Licensed Practical Nurse (LPN) #170 for 01/09/25 revealed that she was on duty at the facility on 01/09/25 from 8:20 A.M. until 12:52 P.M.
Review of the attestation statements on 04/03/25 authored by Scheduler #175, Registered Nurse #155, and the Director of Nursing regarding the events of 01/09/25 revealed that on 01/09/25, LPN #170 was the nurse working on the first and second floors of the facility. She left the building on 01/09/25 at 12:52 P.M. after claiming she was too anxious to complete her shift. LPN #170 left the faciity on [DATE] without signing off the medication administration record in its entirety for Resident #5. RN #155, a member of the facility's nursing administration team, completed the duration of LPN #170's shift, and LPN #170 was reported to the nursing board for job abandonment.